| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/14/2000 | CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | CA2366642A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | CA2366615A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | CA2366429A1 Methods and compositions for regulating memory consolidation |
| 09/14/2000 | CA2366260A1 Heterocyclic compounds having effect of activating .alpha.4.beta.2 nicotinic acetylcholine receptors |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2362319A1 Imidazole compounds as histamine h3 ligands |
| 09/13/2000 | EP1035115A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
| 09/13/2000 | EP1034265A1 Human cdc10 homolog |
| 09/13/2000 | EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening |
| 09/13/2000 | EP1034255A1 Lineage restricted glial precursors from the central nervous system |
| 09/13/2000 | EP1034176A1 Thiophene-sulfonamide compounds |
| 09/13/2000 | EP1034174A1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
| 09/13/2000 | EP1034171A1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl1]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 09/13/2000 | EP1034170A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) |
| 09/13/2000 | EP1033998A1 Method of suppressing beta-amyloid-related changes in alzheimer's disease |
| 09/13/2000 | EP1033996A1 Prevention and treatment of amyloidogenic disease |
| 09/13/2000 | EP1033990A1 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids |
| 09/13/2000 | EP1033988A1 Parenteral formulations comprising carbamazepine or its derivatives |
| 09/13/2000 | EP1033987A2 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 09/13/2000 | EP1033986A1 Formulations comprising dissolved paroxetine |
| 09/13/2000 | EP1033979A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods |
| 09/13/2000 | EP1033978A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0851761A4 Anti-intoxication composition |
| 09/13/2000 | EP0850050B1 Oral fast-dissolving compositions for dopamine agonists |
| 09/13/2000 | EP0839146B1 Piperazine derivatives and their use as 5-ht1a antagonists |
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/13/2000 | CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 09/13/2000 | CN1266368A Heterocyclic vinylethers against neurological disorders |
| 09/13/2000 | CN1266057A Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
| 09/13/2000 | CN1266053A Substituted cycloheptaene and its preparation process and use |
| 09/13/2000 | CN1056374C Tricyclic diazepine vasopression antagonists |
| 09/13/2000 | CN1056373C Process for preparation of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 09/13/2000 | CN1056308C Medicine for adjusting cranial nerve function |
| 09/13/2000 | CN1056307C Epiplesy curing powder |
| 09/13/2000 | CN1056297C Cool health care medicine |
| 09/13/2000 | CN1056284C Traditional Chinese medicinal preparation for treating epilepsy |
| 09/12/2000 | US6117989 Human calcium-binding proteins |
| 09/12/2000 | US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117900 Use of retigabine for the treatment of neuropathic pain |
| 09/12/2000 | US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 09/12/2000 | US6117895 Dialkoxyphenyl-substituted oxazolidinones |
| 09/12/2000 | US6117883 Useful for modulating a muscarinic receptor. |
| 09/12/2000 | US6117882 5-HT4 agonists and antagonists |
| 09/12/2000 | US6117873 Can be used for the treatment of pathological conditions which respond to blockage of excitatory amino acid receptors |
| 09/12/2000 | US6117853 Cerebration improver |
| 09/12/2000 | US6117840 Inhibits binding between vla-4 receptor expressed on inflammatory leukocytes and fibronectin cs-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states |
| 09/12/2000 | US6117424 Compositions of mononuclear phagocytes useful for promoting axonal regeneration |
| 09/12/2000 | US6117421 Method for promoting cell growth and immunosuppression using chaperonin |
| 09/12/2000 | CA2105384C Treatment of addiction to drugs and substances of abuse |
| 09/08/2000 | WO2000052210A2 Methods for targeting rna molecules |
| 09/08/2000 | WO2000052205A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 09/08/2000 | WO2000052145A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | WO2000052048A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052002A1 N-substituted imide derivatives with serotonergic activity |
| 09/08/2000 | WO2000051998A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/08/2000 | WO2000051986A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/08/2000 | WO2000051985A1 Fluorides of 4-substituted piperidine derivatives |
| 09/08/2000 | WO2000051984A1 2-aryl indole derivatives as antagonists of tachykinins |
| 09/08/2000 | WO2000051981A1 Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics |
| 09/08/2000 | WO2000051972A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051970A1 Amide compounds for the potentiation of cholinergic activity |
| 09/08/2000 | WO2000051685A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| 09/08/2000 | WO2000051684A2 Regulators of coenzyme-a-independent transacylase as psychotropic drugs |
| 09/08/2000 | WO2000051632A2 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE |
| 09/08/2000 | WO2000051595A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | WO2000051577A2 Use of fluorinated triazoles for treating pain and affective or attention disorders |
| 09/08/2000 | WO2000051546A2 Bupropion metabolites and methods of their synthesis and use |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027418A3 A method for treating tissue damaged from ischemia |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000007583A3 Treatment of addiction and addiction-related behavior |
| 09/08/2000 | WO1999060987A9 Control of pain with endogenous cannabinoids |
| 09/08/2000 | CA2371934A1 Copper agonist that binds on the copper binding site of app and/or exerts and inhibiting effect on the release of amyloid a.beta. peptide |
| 09/08/2000 | CA2365032A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 09/08/2000 | CA2364415A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | CA2364127A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| 09/08/2000 | CA2363077A1 Methods for targeting rna molecules |
| 09/08/2000 | CA2362825A1 Cdna for human methylenetetrahydrofolate reductase |
| 09/08/2000 | CA2362489A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | CA2362361A1 Bupropion metabolites and methods of their synthesis and use |
| 09/08/2000 | CA2361182A1 N-substituted imide derivatives with serotonergic activity |
| 09/08/2000 | CA2360740A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/08/2000 | CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/07/2000 | DE19909357A1 Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt Kupferagonist which binds to the copper binding site of APP and / or exerts an inhibitory effect on the release of the amyloid Aß-peptide |
| 09/06/2000 | EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| 09/06/2000 | EP1033131A1 Composition of ingredients for a beverage having a delayed aversion effect |
| 09/06/2000 | EP1032838A1 125 human secreted proteins |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032572A2 Pyranones, method for the production and use thereof |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032570A1 Isoquinoline derivatives and their therapeutical use |
| 09/06/2000 | EP1032569A1 Imidazole derivatives, preparation and therapeutic application thereof |